209 results on '"Coyle, Luke"'
Search Results
2. An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL
3. New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids
4. Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma
5. Central Nervous System (CNS) T-Cell Lymphoma as the Presenting Manifestation of Late-Onset Combined Immunodeficiency
6. A dynamic model of the intestinal epithelium integrates multiple sources of preclinical data and enables clinical translation of drug‐induced toxicity
7. Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
8. Unusual presentations of central nervous system myeloid sarcoma
9. Results from a phase 1b study of blinatumomab-pembrolizumab combination in adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
10. An Association between Normal D-dimer Levels at Diagnosis and Improved Survival in a Group of Acute Myeloid Leukaemia Patients
11. A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids
12. Unravelling Mechanisms of Doxorubicin-Induced Toxicity in 3D Human Intestinal Organoids
13. Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
14. AXONAL EXCITABILITY IN PRIMARY AMYLOIDOTIC NEUROPATHY
15. 084 Neurological presentations of rare chloromas in the context of haematological malignancy
16. An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators
17. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
18. Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
19. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease
20. Elevated serum FGF23 concentrations in plasma cell dyscrasias
21. Updated Analysis of an Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
22. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study
23. Adult B‐ and T‐lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes—a short report from two Sydney centres
24. Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma
25. Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
26. Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival
27. SEVERE ANAPHYLAXIS PROVOKED BY IgE-MEDIATED REACTIONS TO FOOD (RED MEAT) IN TWO PATIENTS WITH SYSTEMIC MASTOCYTOSIS: 24.
28. Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.
29. Laboratory monitoring of patients with heparin induced thrombocytopenia: the influence of lepirudin and warfarin on APTT, ecarin clotting time and INR: 38
30. Serum vascular endothelial growth factor (VEGF) level can be used as a diagnostic marker in POEMS syndrome
31. Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia
32. Durability of complete response after blinatumomab therapy for refractory/relapsed aggressive B-cell non-Hodgkin lymphoma.
33. Molecular analysis of the leukaemic B cell in adult and childhood acute lymphoblastic leukaemia
34. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL
35. Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of JH-proximal variable gene segments
36. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
37. Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival.
38. Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
39. 1139. Novel Formulation SUBA-Itraconazole Prophylaxis in Patients With Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow-up Survival Data
40. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome successfully treated with mepolizumab
41. New Formulation Suba-Itraconazole Prophylaxis in Patients with Haematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation
42. Impedance-Based Assessment of Preclinical Cardiac Structural Toxicity Using Human iPSC-Derived Cardiomyocytes and its Correlation to In Vivo (dog) Exposures
43. Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
44. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities
45. Bilateral extramedullary adrenal plasmacytoma: case report and review of the literature
46. Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival
47. ASCIA-P75: ELEVATED VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PLAYS AN IMPORTANT ROLE IN THE DIAGNOSIS OF POEMS SYNDROME
48. Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT
49. Risk Stratification Combining MYC Immunohistochemistry with Standard IPI Has Utility in Patients with Diffuse Large B-Cell Lymphoma
50. Interim Positron Emission Tomography-Computed Tomography (PET-CT) Is Predictive of Post-Therapy Outcome in High Grade Transformation of Low Grade Lymphoproliferative Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.